{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:06:24Z","timestamp":1768683984770,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep06565","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T09:06:00Z","timestamp":1412845560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL"],"prefix":"10.1038","volume":"4","author":[{"given":"Luciana M.","family":"Fontanari Krause","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Sophia","family":"Japp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Mooster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"M\u00fcschen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan K.","family":"Bohlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"key":"BFsrep06565_CR1","first-page":"59","volume":"36","author":"JD Rowley","year":"1999","unstructured":"Rowley, J. D. The role of chromosome translocations in leukemogenesis. Semin. Hematol. 36, 59\u201372 (1999).","journal-title":"Semin. Hematol."},{"key":"BFsrep06565_CR2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000056818","volume":"91","author":"SK Bohlander","year":"2000","unstructured":"Bohlander, S. K. Fusion genes in leukemia: An emerging network. Cytogenet. Cell Genet. 91, 52\u201356 (2000).","journal-title":"Cytogenet. Cell Genet."},{"key":"BFsrep06565_CR3","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.febslet.2010.04.002","volume":"584","author":"JHA Martens","year":"2010","unstructured":"Martens, J. H. A. & Stunnenberg, H. G. The molecular signature of oncofusion proteins in acute myeloid leukemia. FEBS Lett. 584, 2662\u20132669 (2010).","journal-title":"FEBS Lett."},{"key":"BFsrep06565_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/372143a0","volume":"372","author":"TH Rabbitts","year":"1994","unstructured":"Rabbitts, T. H. Chromosomal translocations in human cancer. Nature 372, 143\u2013149 (1994).","journal-title":"Nature"},{"key":"BFsrep06565_CR5","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1172\/JCI17595","volume":"112","author":"M Alcalay","year":"2003","unstructured":"Alcalay, M. et al. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J. Clin. Invest. 112, 1751\u20131761 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFsrep06565_CR6","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1073\/pnas.1111498108","volume":"108","author":"D Biswas","year":"2011","unstructured":"Biswas, D. et al. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes. Proc. Natl. Acad. Sci. U. S. A. 108, 15751\u201315756 (2011).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep06565_CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","volume":"77","author":"TR Golub","year":"1994","unstructured":"Golub, T. R., Barker, G. F., Lovett, M. & Gilliland, D. G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77, 307\u2013316 (1994).","journal-title":"Cell"},{"key":"BFsrep06565_CR8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.leukres.2012.04.010","volume":"36","author":"E De Braekeleer","year":"2012","unstructured":"De Braekeleer, E. et al. ETV6 fusion genes in hematological malignancies: A review. Leuk. Res. 36, 945\u2013961 (2012).","journal-title":"Leuk. Res."},{"key":"BFsrep06565_CR9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.semcancer.2005.01.008","volume":"15","author":"SK Bohlander","year":"2005","unstructured":"Bohlander, S. K. ETV6: A versatile player in leukemogenesis. Semin. Cancer Biol. 15, 162\u2013174 (2005).","journal-title":"Semin. Cancer Biol."},{"key":"BFsrep06565_CR10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2264(199704)18:4<254::AID-GCC3>3.0.CO;2-#","volume":"18","author":"Y Suto","year":"1997","unstructured":"Suto, Y., Sato, Y., Smith, S. D., Rowley, J. D. & Bohlander, S. K. A t(6;12)(q23;p13) results in the fusion of ETV6 to a novel gene, STL, in a b-cell ALL cell line. Genes Chromosomes Cancer 18, 254\u2013268 (1997).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFsrep06565_CR11","first-page":"1865","volume":"7","author":"LQ Zhang","year":"1993","unstructured":"Zhang, L. Q. et al. Establishment of cell lines from b-cell precursor acute lymphoblastic leukemia. Leukemia 7, 1865\u20131874 (1993).","journal-title":"Leukemia"},{"key":"BFsrep06565_CR12","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1182\/blood.V84.10.3473.3473","volume":"84","author":"H Kobayashi","year":"1994","unstructured":"Kobayashi, H. et al. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood 84, 3473\u20133482 (1994).","journal-title":"Blood"},{"key":"BFsrep06565_CR13","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1182\/blood.V76.8.1626.1626","volume":"76","author":"Y Hayashi","year":"1990","unstructured":"Hayashi, Y. et al. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood 76, 1626\u20131630 (1990).","journal-title":"Blood"},{"key":"BFsrep06565_CR14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","volume":"123","author":"A Bouska","year":"2014","unstructured":"Bouska, A. et al. Genome-wide copy number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood 123, 1681\u20131690 (2014).","journal-title":"Blood"},{"key":"BFsrep06565_CR15","first-page":"122","volume":"27","author":"JD Rowley","year":"1990","unstructured":"Rowley, J. D. Recurring chromosome abnormalities in leukemia and lymphoma. Semin. Hematol. 27, 122\u2013136 (1990).","journal-title":"Semin. Hematol."},{"key":"BFsrep06565_CR16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.leu.2400555","volume":"11","author":"DM Jadayel","year":"1997","unstructured":"Jadayel, D. M. et al. Potential role for concurrent abnormalities of the cyclin D1, p16cdkn2 and p15cdkn2b genes in certain B cell non-hodgkin's lymphomas. Functional studies in a cell line (granta 519). Leukemia 11, 64\u201372 (1997).","journal-title":"Leukemia"},{"key":"BFsrep06565_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.1994.tb04726.x","volume":"86","author":"J Greil","year":"1994","unstructured":"Greil, J. et al. The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7. Br. J. Haematol. 86, 275\u2013283 (1994).","journal-title":"Br. J. Haematol."},{"key":"BFsrep06565_CR18","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1073\/pnas.1310656110","volume":"110","author":"H Huang","year":"2013","unstructured":"Huang, H. et al. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc. Natl. Acad. Sci. U. S. A. 110, 11994\u201311999 (2013).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep06565_CR19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/leu.2011.307","volume":"26","author":"MA Mulaw","year":"2012","unstructured":"Mulaw, M. A. et al. CALM\/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12. Leukemia 26, 1012\u20131019 (2012).","journal-title":"Leukemia"},{"key":"BFsrep06565_CR20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2009-03-209395","volume":"114","author":"Y-H Lin","year":"2009","unstructured":"Lin, Y.-H. et al. Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias. Blood 114, 651\u2013658 (2009).","journal-title":"Blood"},{"key":"BFsrep06565_CR21","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/sj.onc.1210945","volume":"27","author":"PA Greif","year":"2008","unstructured":"Greif, P. A., Tizazu, B., Krause, A., Kremmer, E. & Bohlander, S. K. The leukemogenic CALM\/AF10 fusion protein alters the subcellular localization of the lymphoid regulator ikaros. Oncogene 27, 2886\u20132896 (2008).","journal-title":"Oncogene"},{"key":"BFsrep06565_CR22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tibs.2011.11.001","volume":"37","author":"R Budhidarmo","year":"2012","unstructured":"Budhidarmo, R., Nakatani, Y. & Day, C. L. RINGs hold the key to ubiquitin transfer. Trends Biochem. Sci. 37, 58\u201365 (2012).","journal-title":"Trends Biochem. Sci."},{"key":"BFsrep06565_CR23","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1182\/blood-2009-07-231191","volume":"115","author":"GW Xu","year":"2010","unstructured":"Xu, G. W. et al. The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma. Blood 115, 2251\u20132259 (2010).","journal-title":"Blood"},{"key":"BFsrep06565_CR24","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1073\/pnas.1301045110","volume":"110","author":"E Wang","year":"2013","unstructured":"Wang, E. et al. Histone H2B ubiquitin ligase RNF20 is required for mll-rearranged leukemia. Proc. Natl. Acad. Sci. U. S. A. 110, 3901\u20133906 (2013).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep06565_CR25","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1038\/onc.2012.406","volume":"32","author":"D Guan","year":"2013","unstructured":"Guan, D., Factor, D., Liu, Y., Wang, Z. & Kao, H.-Y. The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein. Oncogene 32, 3819\u20133828 (2013).","journal-title":"Oncogene"},{"key":"BFsrep06565_CR26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ccr.2013.01.025","volume":"23","author":"L Reavie","year":"2013","unstructured":"Reavie, L. et al. Regulation of c-myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Cancer Cell 23, 362\u2013375 (2013).","journal-title":"Cancer Cell"},{"key":"BFsrep06565_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1586\/era.13.4","volume":"13","author":"D Niewerth","year":"2013","unstructured":"Niewerth, D., Dingjan, I., Cloos, J., Jansen, G. & Kaspers, G. Proteasome inhibitors in acute leukemia. Expert Rev. Anticancer Ther. 13, 327\u2013337 (2013).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"BFsrep06565_CR28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/157489211796957775","volume":"6","author":"R Masetti","year":"2011","unstructured":"Masetti, R., Kleinschmidt, K., Biagi, C. & Pession, A. Emerging targeted therapies for pediatric acute myeloid leukemia. Recent. Pat. Anticancer Drug Discov. 6, 354\u2013366 (2011).","journal-title":"Recent. Pat. Anticancer Drug Discov."},{"key":"BFsrep06565_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3324\/haematol.11666","volume":"93","author":"E Colado","year":"2008","unstructured":"Colado, E. et al. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype. Haematologica 93, 57\u201366 (2008).","journal-title":"Haematologica"},{"key":"BFsrep06565_CR30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gcc.10057","volume":"34","author":"H Tagawa","year":"2002","unstructured":"Tagawa, H. et al. Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in t-cell lymphoma\/leukemia cell lines. Genes Chromosomes Cancer 34, 175\u2013185 (2002).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFsrep06565_CR31","doi-asserted-by":"crossref","first-page":"31616","DOI":"10.1074\/jbc.M110.154120","volume":"285","author":"C Gorbea","year":"2010","unstructured":"Gorbea, C. et al. A protein interaction network for ecm29 links the 26 S proteasome to molecular motors and endosomal components. J. Biol. Chem. 285, 31616\u201331633 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFsrep06565_CR32","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.158.6.2736","volume":"158","author":"Y Suzuki","year":"1997","unstructured":"Suzuki, Y. et al. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of src family tyrosine kinases. J. Immunol. 158, 2736\u20132744 (1997).","journal-title":"J. Immunol."},{"key":"BFsrep06565_CR33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ng1940","volume":"39","author":"C Klein","year":"2007","unstructured":"Klein, C. et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat. Genet. 39, 86\u201392 (2007).","journal-title":"Nat. Genet."},{"key":"BFsrep06565_CR34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2121-13-20","volume":"13","author":"B Li","year":"2012","unstructured":"Li, B. et al. Hax-1 is rapidly degraded by the proteasome dependent on its PEST sequence. BMC Cell Biol. 13, 20 (2012).","journal-title":"BMC Cell Biol."},{"key":"BFsrep06565_CR35","doi-asserted-by":"crossref","first-page":"50295","DOI":"10.1074\/jbc.M406006200","volume":"279","author":"L Cilenti","year":"2004","unstructured":"Cilenti, L. et al. Regulation of HAX-1 anti-apoptotic protein by omi\/htra2 protease during cell death. J. Biol. Chem. 279, 50295\u201350301 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFsrep06565_CR36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1016-8478(23)17554-6","volume":"25","author":"AY Lee","year":"2008","unstructured":"Lee, A. Y. et al. HS 1-associated protein X-1 is cleaved by caspase-3 during apoptosis. Mol. Cells 25, 86\u201390 (2008).","journal-title":"Mol. Cells"},{"key":"BFsrep06565_CR37","doi-asserted-by":"crossref","first-page":"22461","DOI":"10.1074\/jbc.M109.086587","volume":"285","author":"J Han","year":"2010","unstructured":"Han, J. et al. Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct hax-1 cleavage. J. Biol. Chem. 285, 22461\u201322472 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFsrep06565_CR38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature06604","volume":"452","author":"J-R Chao","year":"2008","unstructured":"Chao, J.-R. et al. Hax1-mediated processing of htra2 by parl allows survival of lymphocytes and neurons. Nature 452, 98\u2013102 (2008).","journal-title":"Nature"},{"key":"BFsrep06565_CR39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbrc.2010.02.084","volume":"393","author":"YJ Kang","year":"2010","unstructured":"Kang, Y. J. et al. Molecular interaction between HAX-1 and XIAP inhibits apoptosis. Biochem. Biophys. Res. Commun. 393, 794\u2013799 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFsrep06565_CR40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.RES.0000237387.05259.a5","volume":"99","author":"Y Han","year":"2006","unstructured":"Han, Y. et al. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ. Res. 99, 415\u2013423 (2006).","journal-title":"Circ. Res."},{"key":"BFsrep06565_CR41","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s10620-012-2108-5","volume":"57","author":"S-J Sun","year":"2012","unstructured":"Sun, S.-J., Feng, L., Zhao, G.-Q. & Dong, Z.-M. HAX-1 promotes the chemoresistance, invasion and tumorigenicity of esophageal squamous carcinoma cells. Dig. Dis. Sci. 57, 1838\u20131846 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"BFsrep06565_CR42","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/leu.2010.321","volume":"25","author":"A Kwiecinska","year":"2011","unstructured":"Kwiecinska, A. et al. HAX-1 expression in human B lymphoma. Leukemia 25, 868\u2013872 (2011).","journal-title":"Leukemia"},{"key":"BFsrep06565_CR43","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/eji.200940221","volume":"40","author":"D Peckl-Schmid","year":"2010","unstructured":"Peckl-Schmid, D. et al. HAX1 deficiency: Impact on lymphopoiesis and B-cell development. Eur. J. Immunol. 40, 3161\u20133172 (2010).","journal-title":"Eur. J. Immunol."},{"key":"BFsrep06565_CR44","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/nm.2958","volume":"18","author":"J Skokowa","year":"2012","unstructured":"Skokowa, J. et al. Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for g-csf-triggered granulopoiesis. Nat. Med. 18, 1550\u20131559 (2012).","journal-title":"Nat. Med."},{"key":"BFsrep06565_CR45","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.4081\/pr.2011.s2.e9","volume":"3","author":"P Vandenberghe","year":"2011","unstructured":"Vandenberghe, P. & Beel, K. Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML\/MDS. Pediatr. Rep. 3 Suppl2e9 (2011).","journal-title":"Pediatr. Rep."},{"key":"BFsrep06565_CR46","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nrg3594","volume":"14","author":"V Pelechano","year":"2013","unstructured":"Pelechano, V. & Steinmetz, L. M. Gene regulation by antisense transcription. Nature Reviews Genetics 14, 880\u2013893 (2013).","journal-title":"Nature Reviews Genetics"},{"key":"BFsrep06565_CR47","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/nsmb.2428","volume":"19","author":"S Guil","year":"2012","unstructured":"Guil, S. & Esteller, M. Cis-acting noncoding rRNAs: Friends and foes. Nat. Struct. Mol. Biol. 19, 1068\u20131075 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFsrep06565_CR48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cell.2007.01.032","volume":"128","author":"PK Yang","year":"2007","unstructured":"Yang, P. K. & Kuroda, M. I. Noncoding rnas and intranuclear positioning in monoallelic gene expression. Cell 128, 777\u2013786 (2007).","journal-title":"Cell"},{"key":"BFsrep06565_CR49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00439-011-1008-7","volume":"130","author":"DB Pontier","year":"2011","unstructured":"Pontier, D. B. & Gribnau, J. Xist regulation and function explored. Hum. Genet. 130, 223\u2013236 (2011).","journal-title":"Hum. Genet."},{"key":"BFsrep06565_CR50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.201304152","volume":"204","author":"H Zhang","year":"2014","unstructured":"Zhang, H. et al. Long noncoding rna-mediated intrachromosomal interactions promote imprinting at the kcnq1 locus. J. Cell Biol. 204, 61\u201375 (2014).","journal-title":"J. Cell Biol."},{"key":"BFsrep06565_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/75546","volume":"25","author":"R Lyle","year":"2000","unstructured":"Lyle, R. et al. The imprinted antisense RNA at the igf2r locus overlaps but does not imprint mas1. Nat. Genet. 25, 19\u201321 (2000).","journal-title":"Nat. Genet."},{"key":"BFsrep06565_CR52","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.1163802","volume":"322","author":"T Nagano","year":"2008","unstructured":"Nagano, T. et al. The air noncoding RNA epigenetically silences transcription by targeting g9a to chromatin. Science 322, 1717\u20131720 (2008).","journal-title":"Science"},{"key":"BFsrep06565_CR53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MED.0000000000000037","volume":"21","author":"S Azzi","year":"2014","unstructured":"Azzi, S., Abi Habib, W. & Netchine, I. Beckwith-Wiedemann and Russell-Silver syndromes: From new molecular insights to the comprehension of imprinting regulation. Curr. Opin. Endocrinol. Diabetes Obes. 21, 30\u201338 (2014).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"BFsrep06565_CR54","first-page":"1900","volume":"63","author":"TH Vu","year":"2003","unstructured":"Vu, T. H., Chuyen, N. V., Li, T. & Hoffman, A. R. Loss of imprinting of IGF2 sense and antisense transcripts in wilms' tumor. Cancer Res. 63, 1900\u20131905 (2003).","journal-title":"Cancer Res."},{"key":"BFsrep06565_CR55","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.4049\/jimmunol.0900603","volume":"182","author":"KC Pang","year":"2009","unstructured":"Pang, K. C. et al. Genome-wide identification of long noncoding rnas in CD8+ T cells. J. Immunol. 182, 7738\u20137748 (2009).","journal-title":"J. Immunol."},{"key":"BFsrep06565_CR56","first-page":"564","volume":"57","author":"P Peeters","year":"1997","unstructured":"Peeters, P. et al. Fusion of ETV6 to MDS1\/EVI1 as a result of t(3; 12)(q26; p13) in myeloproliferative disorders. Cancer Res. 57, 564\u2013569 (1997).","journal-title":"Cancer Res."},{"key":"BFsrep06565_CR57","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1182\/blood.V99.5.1776","volume":"99","author":"J Cools","year":"2002","unstructured":"Cools, J. et al. Evidence for position effects as a variant etv6-mediated leukemogenic mechanism in myeloid leukemias with at t(4;12)(q11-q12;p13) or t(5; 12)(q31; p13). Blood 99, 1776\u20131784 (2002).","journal-title":"Blood"},{"key":"BFsrep06565_CR58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.leu.2404994","volume":"22","author":"GR Jalali","year":"2008","unstructured":"Jalali, G. R. et al. Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia. Leukemia 22, 114\u2013123 (2008).","journal-title":"Leukemia"},{"key":"BFsrep06565_CR59","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1073\/pnas.0305555101","volume":"101","author":"VPS Rawat","year":"2004","unstructured":"Rawat, V. P. S. et al. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12; 13)(p13; q12) acute myeloid leukemia. Proc. Natl. Acad. Sci. U. S. A. 101, 817\u2013822 (2004).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep06565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06565","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T18:28:09Z","timestamp":1717439289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep06565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep06565"],"URL":"https:\/\/doi.org\/10.1038\/srep06565","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,9]]},"assertion":[{"value":"11 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6565"}}